FDA Oversight of the Tissue Bank Industry

DSpace/Manakin Repository

dc.contributor.advisor	Hutt, Peter Barton	en_US
dc.contributor.author	Wang, Mary H.	en_US
dc.date.accessioned	2012-06-07T20:45:45Z
dc.date.issued	2002	en_US
dc.identifier.citation	FDA Oversight of the Tissue Bank Industry (2002 Third Year Paper)	en
dc.identifier.uri	http://nrs.harvard.edu/urn-3:HUL.InstRepos:8852205
dc.description.abstract	Until recently, FDA oversight of the human tissue industry has been spotty, even nonexistent. However, industry explosion has forced the FDA to not only publish general industry standards in 1993 (finalized in 1997), but to update those standards with more comprehensive rules that are currently being reviewed. Needless to say, lack of adequate funding has proven problematic for the cash-strapped agency in terms of enforcing any regulations the agency hopes to promulgate.	en
dc.language.iso	en_US	en
dash.license	LAA	en_US
dc.subject	Food and Drug Law	en
dc.subject	human	en
dc.subject	tissue	en
dc.subject	industry	en
dc.subject	banking	en
dc.subject	oversight	en
dc.subject	regulation	en
dc.title	FDA Oversight of the Tissue Bank Industry	en
dc.type	Paper (for course/seminar/workshop)	en_US
dc.date.available	2012-06-07T20:45:45Z

Files	Size	Format	View
tissue_donation_paper_final_with_abstract.pdf	208.0Kb	PDF	View/Open
tissue_donation_paper_final_with_abstract.rtf	93.83Kb	RTF file	View/Open
tissue_donation_paper_final_with_abstract.html	74.60Kb	HTML	View/Open